Dyne Therapeutics IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 25.73 USD | 26,26 USD | 9,57 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 39,533 USD | 7 | 6 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 186.746.431 | 17,25 | 8,91 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Dyne Therapeutics Inc
Mitarbeiter 263
Handelsplatz NASDAQ
Ticker Symbol DYN
IPO Datum 2020-09-17
Adresse 1560 Trapelo Road, Waltham, MA, United States, 02451
Webseite https://www.dyne-tx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. John G. Cox M.B.A. | CEO, President & Director |
| 2 | Mr. Erick J. Lucera C.F.A., CPA | CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer |
| 3 | Dr. Oxana Beskrovnaya Ph.D. | Chief Innovation Officer |
| 4 | Ms. Johanna Friedl-Naderer | Chief Commercial Officer |
| 5 | Dr. Douglas Kerr M.B.A., M.D., Ph.D. | Chief Medical Officer |
| 6 | Dr. Axel Wiest | Senior VP and Head of Portfolio Strategy & Operations |
| 7 | Dr. Rajesh Manchanda Ph.D. | Chief Technical Officer |
| 8 | Mr. James P. Bilotta M.B.A. | Chief Digital & Information Officer |
| 9 | Mr. Daniel Wilson | Senior VP & Head of Legal |
| 10 | Ms. Lucia Celona | Chief Human Resource Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | T. Rowe Price Investment Management,Inc. | 0,00% | 0,00 Mio. USD |
| 2 | HHG PLC | 0,00% | 0,00 Mio. USD |
| 3 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | Atlas Venture Life Science Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 6 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 7 | Orbis Allan Gray Ltd | 0,00% | 0,00 Mio. USD |
| 8 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 9 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Perceptive Advisors LLC | 0,00% | 0,00 Mio. USD |
| 11 | FCPM III SERVICES BV | 0,00% | 0,00 Mio. USD |
| 12 | TCG Crossover Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 14 | Vestal Point Capital LP | 0,00% | 0,00 Mio. USD |
| 15 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 16 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 17 | Armistice Capital, LLC | 0,00% | 0,00 Mio. USD |
| 18 | Frazier Life Sciences Management, L.P. | 0,00% | 0,00 Mio. USD |
| 19 | Orbimed Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 20 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |